mulberroside A
- CAS No.
- 102841-42-9
- Chemical Name:
- mulberroside A
- Synonyms
- mulberroside A;Mulberroside A (Standard);Mulberroside A, 10 mM in DMSO;Mulberroside A, 98%, from Morus alba L.;2,5'-Dihydroxy-4,3'-bis(β-D-glucopyranosyloxy)-trans-stilbene;2,5'-Dihydroxy-4,3'-bis(beta-D-glucopyranosyloxy)-trans-stilbene;b-D-Glucopyranoside,3-[(1E)-2-[4-(b-D-glucopyranosyloxy)-2-hydroxyphenyl]ethenyl]-5-hydroxyphenyl;β-D-Glucopyranoside, 3-[(1E)-2-[4-(β-D-glucopyranosyloxy)-2-hydroxyphenyl]ethenyl]-5-hydroxyphenyl;2-(4-hydroxy-1,3-thiazol-3-ium-3-yl)ethyl [2-(octadecylcarbamoyloxymethyl)oxolan-2-yl]methyl phosphate;beta-D-Glucopyranoside 3-[(1E)-2-[4-(beta-D-glucopyranosyloxy)-2-hydroxyphenyl]ethenyl]-5-hydroxyphenyl
- CBNumber:
- CB41345779
- Molecular Formula:
- C26H32O14
- Molecular Weight:
- 568.52
- MDL Number:
- MFCD16294844
- MOL File:
- 102841-42-9.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Mulberroside A phyproof® Reference Substance | PHL80501 | 10 mg | $548 |
| Mulberroside A ≥98% | 27545 | 25mg | $169 |
| Mulberroside A ≥98% | 27545 | 50mg | $319 |
| Mulberroside A ≥98% | 27545 | 100mg | $602 |
| Mulberroside A ≥98% | 27545 | 250mg | $1253 |
| More product size | |||
| Melting point | 235-236o C |
|---|---|
| Boiling point | 954.7±65.0 °C(Predicted) |
| Density | 1.654 |
| Flash point | 531℃ |
| storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| solubility | DMSO (Slightly, Sonicated), Methanol (Slightly) |
| form | Solid |
| pka | 9.03±0.40(Predicted) |
| color | White to Off-White |
| Major Application | food and beverages |
| Cosmetics Ingredients Functions | SKIN CONDITIONING |
| InChIKey | HPSWAEGGWLOOKT-WVRADKAPNA-N |
| SMILES | O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CC=C(/C=C/C2C=C(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C(O)C=2)C(O)=C1 |&1:1,4,6,8,10,22,23,25,27,29,r| |
| FDA UNII | OJU5SVA08B |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
SAFETY
Risk and Safety Statements
| WGK Germany | WGK 3 |
|---|---|
| HS Code | 29389090 |
| Storage Class | 11 - Combustible Solids |
mulberroside A price More Price(77)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | PHL80501 | Mulberroside A phyproof® Reference Substance | 102841-42-9 | 10 mg | $548 | 2026-04-30 | Buy |
| Cayman Chemical | 27545 | Mulberroside A ≥98% | 102841-42-9 | 25mg | $169 | 2026-04-30 | Buy |
| Cayman Chemical | 27545 | Mulberroside A ≥98% | 102841-42-9 | 50mg | $319 | 2026-04-30 | Buy |
| Cayman Chemical | 27545 | Mulberroside A ≥98% | 102841-42-9 | 100mg | $602 | 2026-04-30 | Buy |
| Cayman Chemical | 27545 | Mulberroside A ≥98% | 102841-42-9 | 250mg | $1253 | 2026-04-30 | Buy |
mulberroside A Chemical Properties,Uses,Production
Description
Mulberroside A is isolated from the ethanol extract of Morus alba root. It has anti-tyrosinase and antioxidant activity and is widely used as an active ingredient in cosmetics.
Chemical Properties
White crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from Morus alba bark.
Uses
Mulberroside A is a stilbenoid found in Morus alba plants. Potential metabolite for Oxyresveratrol (O861920), a natural hydroxystilbene with similar bioactivity to resveratrol. COX-1 inhibitor like resveratrol (R150000), anti-cancer agent.
Definition
ChEBI: Cis-Mulberroside A is a glycoside and a stilbenoid.
in vivo
Mulberroside A (10, 20, and 40 mg/kg) decreases serum uric acid levels and increases urinary urate excretion and fractional excretion of uric acid in hyperuricemic micem[4].
| Animal Model: | Male Kun-Ming mice (20±2 g)[4] |
| Dosage: | 5, 10, 20, and 40 mg/kg; the dose volume 10 mL/kg body weight |
| Administration: | Orally initiated at 9:00 a.m. |
| Result: | 10, 20, and 40 mg/kg significantly increased urinary urate excretion in 24 h, resulting in a remarkable elevation of fractional excretion of uric acid (FEUA), and the highest dose completely reversed FEUA alteration of hyperuricemic mice to normal. |
IC 50
IL-1β; IL-6
mulberroside A Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shaanxi Haibo Biotechnology Co., Ltd | +undefined18602966907 | qinhe02@xaltbio.com | China | 997 | 58 |
| Shanghai Zheyan Biotech Co., Ltd. | 18017610038 | zheyansh@163.com | CHINA | 3619 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29815 | 58 |
| Chengdu GLP biotechnology Co Ltd | 028-87075086 13350802083 | scglp@glp-china.com | CHINA | 1824 | 58 |
| Chengdu Biopurify Phytochemicals Ltd. | +86-28-82633860; +8618080483897 | sales@biopurify.com | China | 4616 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19936 | 58 |
| Shanghai Standard Technology Co., Ltd. | 18502101150 | ft-sales@nature-standard.com | CHINA | 1923 | 58 |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49979 | 58 |
| Wuhan ChemNorm Biotech Co.,Ltd. | +86-27-8439 4403 18971486879 | sales@chemnorm.com | CHINA | 2935 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32466 | 58 |
View Lastest Price from mulberroside A manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-05-11 | Mulberroside A
102841-42-9
|
$42.00-147.00 | 99.40% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2024-04-12 | Mulberroside A
102841-42-9
|
1kg | 99% | 2000ton | Shaanxi Haibo Biotechnology Co., Ltd | ||
![]() |
2023-02-24 | Mulberroside A
102841-42-9
|
5mg | ≥98%(HPLC) | 10 g | Shanghai Standard Technology Co., Ltd. |
-

- Mulberroside A
102841-42-9
- $42.00-147.00
- 99.40%
- TargetMol Chemicals Inc.
-

- Mulberroside A
102841-42-9
- $0.00
- 99%
- Shaanxi Haibo Biotechnology Co., Ltd
-

- Mulberroside A
102841-42-9
- $0.00
- ≥98%(HPLC)
- Shanghai Standard Technology Co., Ltd.




